发明授权
- 专利标题： CXCR2 inhibitors
- 专利标题（中）： CXCR2抑制剂
-
申请号： US12337980申请日： 2008-12-18
-
公开(公告)号： US08980938B2公开(公告)日： 2015-03-17
- 发明人: Stephanie Hachtel , Juergen Dedio , Josef Pernerstorfer , Stephen Shimshock , Carolina Lanter
- 申请人： Stephanie Hachtel , Juergen Dedio , Josef Pernerstorfer , Stephen Shimshock , Carolina Lanter
- 申请人地址： FR Paris
- 专利权人： Sanofi
- 当前专利权人： Sanofi
- 当前专利权人地址： FR Paris
- 代理机构： Scully, Scott, Murphy & Presser, P.C.
- 优先权： EP06013591 20060630
- 主分类号： A01N43/12
- IPC分类号： A01N43/12 ; A61K31/38 ; A01N43/02 ; C07D333/52 ; C07D333/72 ; C07D409/02 ; C07D333/16 ; C07C235/66 ; C07D333/54
摘要：
The invention relates to compounds of the formula I in which R1, R2, A, B, X and Y have the meanings indicated in the claims, and/or a pharmaceutically acceptable salt and/or a prodrug thereof. Because of their properties as inhibitors of chemokine receptors, especially as CXCR2 inhibitors, the compounds of the formula I and the pharmaceutically acceptable salts and prodrugs thereof are suitable for the prevention and treatment of chemokine mediated diseases.
公开/授权文献
- US20090258936A1 CXCR2 INHIBITORS 公开/授权日：2009-10-15